We are live on
!
Find out more
BA
BlackRock Advisors Portfolio holdings
AUM
$98.8B
1-Year Est. Return
15.8%
This Fund
S&P 500
This Quarter
Est. Return
-7.26%
1 Year Est. Return
+15.8%
3 Year Est. Return
+32.35%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$93.3B
AUM Growth
-$2.89B
(-3%)
Cap. Flow
+$5.74B
Cap. Flow
% of AUM
6.15%
Top 10 Holdings %
Top 10 Hldgs %
15.28%
Holding
3,878
New
163
Increased
1,568
Reduced
1,679
Closed
111
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$423M |
| 2 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$367M |
| 3 |
ExxonMobil
XOM
|
+$337M |
| 4 |
Johnson & Johnson
JNJ
|
+$257M |
| 5 |
Biogen
BIIB
|
+$250M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$195M |
| 2 |
AbbVie
ABBV
|
+$188M |
| 3 |
JPMorgan Chase
JPM
|
+$183M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$176M |
| 5 |
Teva Pharmaceuticals
TEVA
|
+$174M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.49% |
| 2 | Financials | 16.75% |
| 3 | Technology | 9.99% |
| 4 | Industrials | 8.32% |
| 5 | Energy | 7.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AT
3051
DELISTED
Atlantic Power Corporation
AT
| $107K | ﹤0.01% |
57,710
-3,291
| -5% | -$7.89K |
|
3052
Madrigal Pharmaceuticals
MDGL
$12.7B
| $106K | ﹤0.01% |
1,745
-13
| -0.7% | -$938 |
|
|
USAK
3053
DELISTED
USA Truck Inc
USAK
| $106K | ﹤0.01% |
6,144
-382
| -6% | -$7.62K |
|
|
NTLS
3054
DELISTED
NTELOS HLDGS CORP COM
NTLS
| $106K | ﹤0.01% |
11,689
+111
| +1% | +$838 |
|
3055
Vanguard Total Bond Market
BND
$158B
| $105K | ﹤0.01% |
+1,278
| New | +$104K |
|
3056
Clearfield
CLFD
$436M
| $105K | ﹤0.01% |
7,847
-518
| -6% | -$8.78K |
|
3057
KVH Industries
KVHI
$181M
| $105K | ﹤0.01% |
10,469
-755
| -7% | -$8.61K |
|
3058
VirnetX Holding Corp
VHC
$51M
| $105K | ﹤0.01% |
1,476
-6
| -0.4% | -$478 |
|
3059
VSE Corp
VSEC
$5.64B
| $105K | ﹤0.01% |
5,248
-424
| -7% | -$9.62K |
|
|
MODN
3060
DELISTED
MODEL N, INC.
MODN
| $105K | ﹤0.01% |
10,480
-17
| -0.2% | -$184 |
|
|
BBG
3061
DELISTED
Bill Barrett Corp
BBG
| $105K | ﹤0.01% |
31,760
-576,245
| -95% | -$3.01M |
|
|
GDEF
3062
DELISTED
GLOBAL DEFENSE & NATIONAL SECURITY SYSTEMS INC COM
GDEF
| $105K | ﹤0.01% |
10,000
| – | – |
|
|
BIND
3063
DELISTED
BIND THERAPEUTICS INC
BIND
| $105K | ﹤0.01% |
23,650
-80,745
| -77% | -$396K |
|
|
GLF
3064
DELISTED
GulfMark Offshore, Inc. Common Stock
GLF
| $105K | ﹤0.01% |
17,112
+816
| +5% | +$6.95K |
|
|
DEA
3065
Easterly Government Properties
DEA
$1.17B
| $104K | ﹤0.01% |
2,614
-243
| -9% | -$9.58K |
|
3066
CALL
ArcelorMittal
MT
$50.9B
| $104K | ﹤0.01% |
+8,747
| New | +$162K |
|
|
ORC
3067
Orchid Island Capital
ORC
$1.3B
| $104K | ﹤0.01% |
2,258
+410
| +22% | +$18.8K |
|
3068
Freshpet
FRPT
$2.92B
| $103K | ﹤0.01% |
9,848
-440
| -4% | -$6.37K |
|
3069
Lineage Cell Therapeutics
LCTX
$257M
| $103K | ﹤0.01% |
42,576
-5,765
| -12% | -$14.9K |
|
3070
Travelzoo
TZOO
$105M
| $103K | ﹤0.01% |
12,399
-111,283
| -90% | -$1.04M |
|
|
NSTG
3071
DELISTED
NanoString Technologies, Inc.
NSTG
| $103K | ﹤0.01% |
6,431
+58
| +0.9% | +$909 |
|
|
ADVM
3072
DELISTED
Adverum Biotechnologies
ADVM
| $102K | ﹤0.01% |
1,234
+125
| +11% | +$16K |
|
3073
Alico
ALCO
$286M
| $102K | ﹤0.01% |
2,506
+3
| +0.1% | +$130 |
|
3074
First Business Financial Services
FBIZ
$564M
| $102K | ﹤0.01% |
4,320
+50
| +1% | +$1.13K |
|
3075
Ocular Therapeutix
OCUL
$1.89B
| $102K | ﹤0.01% |
7,236
+645
| +10% | +$13K |
|
Similar funds
BIM
BJ
IC
EAM
MFS
CIM
KAM
PFM
BlackRock Advisors's Q3 2015 Portfolio in Review
As of Q3 2015, BlackRock Advisors held 3,878 positions worth $93.3B, down 3% from $96.2B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
BlackRock Advisors deployed $5.74B of net new capital in Q3 2015, opening 163 new positions and adding to 1,568 existing holdings. Its largest new stake was Allergan plc: 186,940 shares worth $176M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 20% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $195M trimmed.
- BlackRock Advisors's largest Q3 2015 buy was Allergan plc: 186,940 shares worth $176M.
- BlackRock Advisors added most to Apple in Q3 2015, an estimated $423M increase.
- BlackRock Advisors's biggest Q3 2015 reduction was Vertex Pharmaceuticals, cutting an estimated $195M.
- BlackRock Advisors fully exited RECEPTOS INC COM STK (DE) in Q3 2015, selling an estimated $108M.
- BlackRock Advisors's ten largest holdings make up 15% of its $93.3B portfolio in Q3 2015.
- BlackRock Advisors opened 163 new positions and closed 111 in Q3 2015.
- BlackRock Advisors's portfolio value fell 3% quarter-over-quarter to $93.3B.
Based on BlackRock Advisors's 13F filing for Q3 2015, filed 13 Nov 2015.